MedPath

The beneficial effects of Cinnamon in controlling the blood glucose levels in diabetic patient

Phase 1
Conditions
Diabetes Mellites
Registration Number
SLCTR/2012/007
Lead Sponsor
Mr. Mahinda Sakalasooriya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

All patients with diabetes (International Classification of Diseases, 9th revision, code for diabetes) with a HbA1c of =/>7.0% on a laboratory blood draw during the last 6 months.

Exclusion Criteria

Age <18 yrs
Pregnancy
Known allergy to cinnamon
End stage renal disease
Cirrhosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in HbA1c level [At baseline and every 3 months for a total of 15 months per patient]<br>
Secondary Outcome Measures
NameTimeMethod
ipid profile [ At baseline and every 3 months<br>]<br>Urinary Micro albumin level [At baseline and every 6 months]<br>Liver Function test (SGOT,SGPT) [At baseline and every 3 months]<br>Renal function tests (serum creatinine, BU) [At baseline and every 3 months]<br>Blood glucose levels (Fasting Blood Glucose) [At baseline and monthly<br> (For a total of 15 months)]<br>Baseline blood pressure [At baseline and monthly<br> (For a total of 15 months)]<br>Clinical assessment of exercise tolerance (history and ECG) [At baseline and monthly<br> (For a total of 15 months)]<br>
© Copyright 2025. All Rights Reserved by MedPath